Clinical Trial

The Food Effect on PK Characteristics and Safety Profiles of PA-111

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.
Trial Details
NCT Number NCT06976489
Lead Sponsor Addpharma Inc.
Conditions Mixed Dyslipidemia
Enrollment 40 participants
Start Date 2025-05
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-16